What is the recommended approach for tapering or discontinuing baricitinib therapy in patients with alopecia areata who have achieved remission?
Featuring Karan Lal, DO, MS, FAAD | Director of Pediatric and Cosmetic Dermatology Affiliated Dermatology Scottsdale, AZ | Published October 01, 2024
Related Media
Powered by Polaris TM